miRNA-124 Prevents Rat Diabetic Retinopathy by Inhibiting the Microglial Inflammatory Response

Diabetic retinopathy (DR) is characterized by vasoregression and glial activation. miRNA-124 (miR-124) reduces retinal microglial activation and alleviates vasoregression in a neurodegenerative rat model. Our aim was to determine whether miR-124 affects vascular and neural damage in the early diabet...

Full description

Bibliographic Details
Main Authors: Ying Chen, Andrea Schlotterer, Luke Kurowski, Lin Li, Marcus Dannehl, Hans-Peter Hammes, Jihong Lin
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/3/2291
_version_ 1797624396337119232
author Ying Chen
Andrea Schlotterer
Luke Kurowski
Lin Li
Marcus Dannehl
Hans-Peter Hammes
Jihong Lin
author_facet Ying Chen
Andrea Schlotterer
Luke Kurowski
Lin Li
Marcus Dannehl
Hans-Peter Hammes
Jihong Lin
author_sort Ying Chen
collection DOAJ
description Diabetic retinopathy (DR) is characterized by vasoregression and glial activation. miRNA-124 (miR-124) reduces retinal microglial activation and alleviates vasoregression in a neurodegenerative rat model. Our aim was to determine whether miR-124 affects vascular and neural damage in the early diabetic retina. Diabetes was induced in 8-week-old <i>Wistar</i> rats by streptozotocin (STZ) injection. At 16 and 20 weeks, the diabetic rats were intravitreally injected with miR-124 mimic, and retinae were analyzed at 24 weeks. Microvascular damage was identified by evaluating pericyte loss and acellular capillary (AC) formation. Müller glial activation was assessed by glial fibrillary acidic protein (GFAP) immunofluorescence staining. Microglial activation was determined by immunofluorescent staining of ionized calcium-binding adaptor molecule 1 (Iba1) in whole mount retinae. The neuroretinal function was assessed by electroretinography. The expression of inflammation-associated genes was evaluated by qRT-PCR. A wound healing assay was performed to quantitate the mobility of microglial cells. The results showed that miR-124 treatment alleviated diabetic vasoregression by reducing AC formation and pericyte loss. miR-124 blunted Müller glial- and microglial activation in diabetic retinae and ameliorated neuroretinal function. The retinal expression of inflammatory factors including <i>Tnf-α</i>, <i>Il-1β</i>, <i>Cd74</i>, <i>Ccl2</i>, <i>Ccl3</i>, <i>Vcam1</i>, <i>Tgf-β1</i>, <i>Arg1</i>, and <i>Il-10</i> was reduced by miR-124 administration. The elevated mobility of microglia upon high glucose exposure was normalized by miR-124. The expression of the transcription factor PU.1 and lipid raft protein Flot1 was downregulated by miR-124. In rat DR, miR-124 prevents vasoregression and glial activation, improves neuroretinal function, and modulates microglial activation and inflammatory responses.
first_indexed 2024-03-11T09:41:48Z
format Article
id doaj.art-5f5f34de6ff04081898ff0b205e14a93
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T09:41:48Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-5f5f34de6ff04081898ff0b205e14a932023-11-16T16:55:08ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-01-01243229110.3390/ijms24032291miRNA-124 Prevents Rat Diabetic Retinopathy by Inhibiting the Microglial Inflammatory ResponseYing Chen0Andrea Schlotterer1Luke Kurowski2Lin Li3Marcus Dannehl4Hans-Peter Hammes5Jihong Lin65th Medical Department, Medical Faculty Mannheim, University of Heidelberg, D-68167 Mannheim, Germany5th Medical Department, Medical Faculty Mannheim, University of Heidelberg, D-68167 Mannheim, Germany5th Medical Department, Medical Faculty Mannheim, University of Heidelberg, D-68167 Mannheim, GermanyDepartment of Vascular Surgery, Medical Faculty Mannheim, University of Heidelberg, D-68167 Mannheim, GermanyDepartment of Pediatrics, Medical Faculty Mannheim, University of Heidelberg, D-68167 Mannheim, Germany5th Medical Department, Medical Faculty Mannheim, University of Heidelberg, D-68167 Mannheim, Germany5th Medical Department, Medical Faculty Mannheim, University of Heidelberg, D-68167 Mannheim, GermanyDiabetic retinopathy (DR) is characterized by vasoregression and glial activation. miRNA-124 (miR-124) reduces retinal microglial activation and alleviates vasoregression in a neurodegenerative rat model. Our aim was to determine whether miR-124 affects vascular and neural damage in the early diabetic retina. Diabetes was induced in 8-week-old <i>Wistar</i> rats by streptozotocin (STZ) injection. At 16 and 20 weeks, the diabetic rats were intravitreally injected with miR-124 mimic, and retinae were analyzed at 24 weeks. Microvascular damage was identified by evaluating pericyte loss and acellular capillary (AC) formation. Müller glial activation was assessed by glial fibrillary acidic protein (GFAP) immunofluorescence staining. Microglial activation was determined by immunofluorescent staining of ionized calcium-binding adaptor molecule 1 (Iba1) in whole mount retinae. The neuroretinal function was assessed by electroretinography. The expression of inflammation-associated genes was evaluated by qRT-PCR. A wound healing assay was performed to quantitate the mobility of microglial cells. The results showed that miR-124 treatment alleviated diabetic vasoregression by reducing AC formation and pericyte loss. miR-124 blunted Müller glial- and microglial activation in diabetic retinae and ameliorated neuroretinal function. The retinal expression of inflammatory factors including <i>Tnf-α</i>, <i>Il-1β</i>, <i>Cd74</i>, <i>Ccl2</i>, <i>Ccl3</i>, <i>Vcam1</i>, <i>Tgf-β1</i>, <i>Arg1</i>, and <i>Il-10</i> was reduced by miR-124 administration. The elevated mobility of microglia upon high glucose exposure was normalized by miR-124. The expression of the transcription factor PU.1 and lipid raft protein Flot1 was downregulated by miR-124. In rat DR, miR-124 prevents vasoregression and glial activation, improves neuroretinal function, and modulates microglial activation and inflammatory responses.https://www.mdpi.com/1422-0067/24/3/2291miR-124microgliavasoregressiondiabetic retinopathy
spellingShingle Ying Chen
Andrea Schlotterer
Luke Kurowski
Lin Li
Marcus Dannehl
Hans-Peter Hammes
Jihong Lin
miRNA-124 Prevents Rat Diabetic Retinopathy by Inhibiting the Microglial Inflammatory Response
International Journal of Molecular Sciences
miR-124
microglia
vasoregression
diabetic retinopathy
title miRNA-124 Prevents Rat Diabetic Retinopathy by Inhibiting the Microglial Inflammatory Response
title_full miRNA-124 Prevents Rat Diabetic Retinopathy by Inhibiting the Microglial Inflammatory Response
title_fullStr miRNA-124 Prevents Rat Diabetic Retinopathy by Inhibiting the Microglial Inflammatory Response
title_full_unstemmed miRNA-124 Prevents Rat Diabetic Retinopathy by Inhibiting the Microglial Inflammatory Response
title_short miRNA-124 Prevents Rat Diabetic Retinopathy by Inhibiting the Microglial Inflammatory Response
title_sort mirna 124 prevents rat diabetic retinopathy by inhibiting the microglial inflammatory response
topic miR-124
microglia
vasoregression
diabetic retinopathy
url https://www.mdpi.com/1422-0067/24/3/2291
work_keys_str_mv AT yingchen mirna124preventsratdiabeticretinopathybyinhibitingthemicroglialinflammatoryresponse
AT andreaschlotterer mirna124preventsratdiabeticretinopathybyinhibitingthemicroglialinflammatoryresponse
AT lukekurowski mirna124preventsratdiabeticretinopathybyinhibitingthemicroglialinflammatoryresponse
AT linli mirna124preventsratdiabeticretinopathybyinhibitingthemicroglialinflammatoryresponse
AT marcusdannehl mirna124preventsratdiabeticretinopathybyinhibitingthemicroglialinflammatoryresponse
AT hanspeterhammes mirna124preventsratdiabeticretinopathybyinhibitingthemicroglialinflammatoryresponse
AT jihonglin mirna124preventsratdiabeticretinopathybyinhibitingthemicroglialinflammatoryresponse